May 29, 2026

Award for Heidelberg Evolutionary Geneticist

Award for Heidelberg Evolutionary Geneticist

Henrik Kaessmann receives Ernst Schering Prize for fundamental contributions to understanding mammalian evolution

Henrik Kaessmann | © Tobias Schwerdt

Prof. Dr Henrik Kaessmann has been selected to receive the 2026 Ernst Schering Prize for his pioneering research into the evolutionary origins and genetic regulation of organ development and organ function. The award, which comes with 50,000 euros in prize money, is presented by the Schering Stiftung and recognizes outstanding scientific achievements in biological, medical or chemical basic research. With his team at the Center for Molecular Biology of Heidelberg University (ZMBH), Prof. Kaessmann investigates the molecular and cellular origins and evolution of vertebrate organs. His systematic, cross-species analyses include jawless vertebrates as well as birds, reptiles and mammals – including humans.

With his studies on the evolution of gene expression and the emergence of new genes, Henrik Kaessmann has fundamentally expanded our understanding of the development of vertebrate organs while pushing conceptual and methodological boundaries, according to the citation for the award to the Heidelberg evolutionary geneticist. In large-scale single-cell studies, Prof. Kaessmann and his team were able, for instance, to identify genetic changes that, over the course of evolution, contributed to the development of the unusually large and complex human brain or to human-specific adaptations in the liver. He has also succeeded in decoding the genetic mechanisms that underlie the evolution of sex chromosomes in mammals, birds and reptiles.

The foundation further states that Henrik Kaessmann’s research, at the interface of evolutionary biology, developmental genomics and molecular biology, combines basic research questions with direct medical relevance. By decoding how genes are activated and controlled in different cells and organs, he creates important frames of reference for biomedical research. His comparative datasets and analyses provide fundamental benchmarks and new starting points for research into a wide range of diseases, particularly those affecting the brain, liver and reproductive organs. Prof. Kaessmann and his team have also identified promising candidate genes that may be linked to disease risks or fertility.

Henrik Kaessmann studied biology at LMU Munich and Uppsala University in Sweden. In 2001, he earned his doctorate from Leipzig University with a dissertation completed at the Max Planck Institute for Evolutionary Anthropology. After a research stay at the University of Chicago in the USA, he moved in 2003 to the Center for Integrative Genomics at the University of Lausanne in Switzerland, where he ultimately served as full professor. In 2015 he accepted an appointment at Heidelberg University’s Faculty of Biosciences. Henrik Kaessmann has received numerous awards for his research, including three substantial grants from the European Research Council (ERC) as well as the Friedrich Miescher Award and the Cloëtta Prize. He is a member of the European Molecular Biology Organization and the German Academy of Sciences Leopoldina.

With its science award, the Schering Stiftung honors researchers worldwide each year whose basic research in biology, chemistry or medicine is pioneering. The award ceremony for the 2026 Ernst Schering Prize to Henrik Kaessmann will take place on 17 November at the Berlin-Brandenburg Academy of Sciences and Humanities in Berlin.

Our latest News

discover more
The Heidelberg and Mannheim University Hospitals consortium has taken first place in the Stern hospital rankings

The Heidelberg and Mannheim University Hospitals consortium has taken first place in the Stern hospital rankings

For the first time in 14 years, there has been a change at the top of the hospital rankings, which are published annually by the MINQ Institute in collaboration with Stern. In its very first year of existence, the Heidelberg and Mannheim University Hospitals Consortium has taken first place. More information in German below: Zusammen […]

Presentation of the EY German Biotechnology Report 2026 in Heidelberg: Strong Innovation Ecosystems Are Key to Scaling Innovation

Presentation of the EY German Biotechnology Report 2026 in Heidelberg: Strong Innovation Ecosystems Are Key to Scaling Innovation

Heidelberg, 11 June 2026 – Germany continues to produce world-class science, breakthrough technologies and highly innovative biotechnology companies. However, the challenge is no longer generating innovation – it is creating the conditions that allow innovation to scale. This was one of the central messages emerging from the presentation of the EY German Biotechnology Report 2026, […]

CELASC 2026 presentation: Impact of topical lidocaine-prilocaine analgesia on pain-induced grooming after ear notching of mice

CELASC 2026 presentation: Impact of topical lidocaine-prilocaine analgesia on pain-induced grooming after ear notching of mice

Finnish animal welfare legislation (Government Decree 1165/2023) effective as of January 1, 2024, requires establishments to apply “appropriate pain relief” in association with ear notching identification method of laboratory rodents(1). However, there is a lack of scientific evidence whether the benefits of applying analgesia outweigh the additional stress related to handling and drug administration. Our […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp